In the last trading session, 2.71 million Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) shares changed hands as the company’s beta touched 1.97. With the company’s per share price at $0.86 changed hands at $0.01 or 1.72% during last session, the market valuation stood at $3.44M. QNRX’s last price was a discount, traded about -618.6% off its 52-week high of $6.18. The share price had its 52-week low at $0.48, which suggests the last value was 44.19% up since then. When we look at Quoin Pharmaceuticals Ltd ADR’s average trading volume, we note the 10-day average is 13.11 million shares, with the 3-month average coming to 2.45 million.
Analysts gave the Quoin Pharmaceuticals Ltd ADR (QNRX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended QNRX as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Quoin Pharmaceuticals Ltd ADR’s EPS for the current quarter is expected to be -0.49.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information
Instantly QNRX was in green as seen at the end of in last trading. With action 69.53%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -82.37%, with the 5-day performance at 69.53% in the green. However, in the 30-day time frame, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) is 62.21% up. Looking at the short shares, we see there were 15195.0 shares sold at short interest cover period of 0.01 days.
Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts
Data shows that the Quoin Pharmaceuticals Ltd ADR share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 31.00% over the past 6 months, a 79.05% in annual growth rate that is considerably higher than the industry average of 17.50%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 67.35%. The 2024 estimates are for Quoin Pharmaceuticals Ltd ADR earnings to increase by 78.94%.
QNRX Dividends
Quoin Pharmaceuticals Ltd ADR is expected to release its next quarterly earnings report on 2024-Nov-06.
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 2.39% of Quoin Pharmaceuticals Ltd ADR shares while 7.73% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.92%.
With 95.0 shares estimated at $82.0 under it, the former controlled 0.00% of total outstanding shares.
